Dr. Anil Bellur Seetharam, MD

Dr. Seetharam practices at Scottsdale Endoscopy Center in Scottsdale, Arizona.

Dr. Seetharam's NPI, 1023229408, was assigned on May 25, 2007. Dr. Seetharam graduated from University of Wisconsin School of Medicine in 2005. Dr. Seetharam holds Arizona license 46305.

Dr. Seetharam's primary practice is Scottsdale Endoscopy Center, at 9787 North 91st Street, Suite 103, Scottsdale, AZ 85258. The practice phone is (480) 657-0889.

Dr. Seetharam's primary practice is Scottsdale Endoscopy Center in Scottsdale, Arizona. Dr. Seetharam is also affiliated with HonorHealth Scottsdale Shea Medical Center. The medical group on file is Arizona Digestive Health. Dmand AI also links Dr. Seetharam to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seetharam practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Seetharam's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Seetharam is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Seetharam is licensed in Arizona.

CMS data shows 1,039 Medicare services from Dr. Seetharam across 11 procedure codes in 2024, for 552 Medicare patients. Medicare paid $95,473 for them.

CMS counts 552 Medicare patients who saw Dr. Seetharam in 2024. The largest group is 65 to 74, with 295 patients. 75% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Seetharam's median patient age at 63, with 50% women.

In 2024, Dr. Seetharam wrote 979 Medicare Part D claims for 444 patients. 78% of them were for generic drugs. CMS names the drug for 814 of them, across 21 drugs with 11 or more claims each, at $506,680 in total drug cost. In 2023, CMS named 347 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Seetharam for performance year 2024, reported as part of a group. Dr. Seetharam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Seetharam as offering telehealth. CMS counts 166 procedures of colonoscopy by Dr. Seetharam, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 35 papers to Dr. Seetharam, published from 2014 to 2022. 2019 was the busiest year, with 5. The most frequent topics are Liver Transplantation, Antiviral Agents and Hepatitis C, Chronic. Dr. Seetharam has published most often in Clin Gastroenterol Hepatol. Dr. Seetharam's most frequent co-authors are Mark Robert Pedersen, MD, Kevin S. Hirsch, MD and Steve Chen, MD.

Dmand AI links Dr. Seetharam to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Liver Cirrhosis, Fibrosis and Non-alcoholic Fatty Liver Disease.

CMS Open Payments shows 587 general payments to Dr. Seetharam from 46 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Gilead Sciences, Inc. paid the most, $91,637.

Dr. Seetharam graduated from University of Wisconsin School of Medicine in 2005.